PHR (Phreesia) EBIT: $7.8 Mil (TTM As of Apr. 2026)


PHR Phreesia Inc PHR
65 GF Score
Price $9.40
GF Value $26.97
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Phreesia EBIT?

Phreesia PHR -1.98% 65 EBIT is $7.8 Mil as of Apr. 2026. GuruFocus rates PHR with a GF Score™ of 65/100 and a GF Value™ of $26.97 (Possible Value Trap). The stock has 3 warning signs investors should review.

Phreesia's earnings before interest and taxes (EBIT) for the three months ended in Apr. 2026 was $7.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Apr. 2026 was $7.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Phreesia's annualized ROC % for the quarter that ended in Apr. 2026 was 3.30%. Phreesia's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 125.75%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Phreesia's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2026 was 1.30%.


Phreesia  (NYSE:PHR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Phreesia's annualized ROC % for the quarter that ended in Apr. 2026 is calculated as:

ROC % (Q: Apr. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2026 ) + Invested Capital (Q: Apr. 2026 ))/ count )
=26.996 * ( 1 - 37.26% )/( (506.822 + 520.167)/ 2 )
=16.9372904/513.4945
=3.30 %

where

Invested Capital(Q: Apr. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=666.141 - 71.268 - ( 74.706 - max(0, 152.109 - 267.261+74.706))
=520.167

Note: The Operating Income data used here is four times the quarterly (Apr. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Phreesia's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Apr. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jan. 2026  Q: Apr. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=28.088/( ( (22.334 + max(-29.333, 0)) + (22.337 + max(-13.295, 0)) )/ 2 )
=28.088/( ( 22.334 + 22.337 )/ 2 )
=28.088/22.3355
=125.75 %

where Working Capital is:

Working Capital(Q: Jan. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(93.296 + 0 + 51.387) - (83.138 + 49.522 + 41.356)
=-29.333

Working Capital(Q: Apr. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(83.201 + 0 + 49.25) - (71.268 + 39.561 + 34.917)
=-13.295

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Apr. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Phreesia's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Apr. 2026 )
=7.779/598.881
=1.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Phreesia EBIT Related Terms


Phreesia EBIT Historical Data

* Premium members only.

The historical data trend for Phreesia's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phreesia EBIT Chart

Phreesia Annual Data
Trend Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
EBIT
Get a 7-Day Free Trial Premium Member Only -116.82 -174.25 -133.49 -53.46 -1.99

Phreesia Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.74 -0.17 5.45 -4.52 7.02

PHR vs HSTM, WEAV, EVH: EBIT Comparison

For the Health Information Services subindustry, Phreesia's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phreesia EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Phreesia's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Phreesia's EV-to-EBIT falls into.


PHR
65GF Score
Phreesia Inc PHR
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phreesia EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $7.8 Mil mean?
Phreesia (PHR) has a EBIT of $7.8 Mil as of Apr. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Phreesia.
Is Phreesia's EBIT too high?
Phreesia's current EBIT is $7.8 Mil. Overall, Phreesia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Phreesia's EBIT compare to HSTM and WEAV?
Phreesia's EBIT of $7.8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Phreesia. Phreesia's current EBIT is $7.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Based on GuruFocus' analysis, Phreesia (PHR) is currently considered Possible Value Trap. The stock's GF Value™ is $26.97, compared to a current price of $9.40 — trading 65.1% below its estimated fair value. The current EBIT is $7.8 Mil. Phreesia's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Phreesia (PHR), the current EBIT is $7.8 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Phreesia (PHR) Overvalued in 2026?

Based on GuruFocus' analysis, Phreesia stock appears to be undervalued. The current stock price of $9.40 is trading 65.1% below its estimated GF Value™ of $26.97. GuruFocus considers Phreesia to be Possible Value Trap.

Key valuation signals for PHR:

  • EBIT: $7.8 Mil
  • GF Value™: $26.97 vs. price of $9.40 (65.1% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the PHR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Phreesia Business Description

Other Exchanges 19P:Germany
Address 1521 Concord Pike, Suite 301, PMB 221, Wilmington, DE, USA, 19803
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
65GF Score

Get the complete analysis for PHR

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.40
Price
$26.97
GF Value